Neuroscience Research Australia
Neuroscience Research Australia (NeuRA) is an independent, not-for-profit medical research institute in Randwick, NSW, conducting neuroscience research on dementia, Parkinson's, schizophrenia, chronic pain and falls for patients, clinicians, pharma partners and academic collaborators.
- Company typePrivate
- Founded1992
- HeadquartersRandwick, Australia
- Headcount251–500
- GTM typeB2B
- OfferingServices
What Neuroscience Research Australia does
Neuroscience Research Australia (NeuRA) is an independent, not-for-profit medical research institute established in 1991 (operating since 1992) and headquartered at the Margarete Ainsworth Building in Randwick, New South Wales, within the Randwick Health & Innovation Precinct and affiliated with the University of New South Wales. The institute conducts basic, translational and clinical neuroscience research across dementia, Parkinson's disease, motor neurone disease, schizophrenia, bipolar disorder, depression, chronic pain, falls prevention and road safety, employing 400+ researchers and staff and producing 352 original research publications, 33 active trials and 128 active projects in FY2024.
NeuRA's core technology platform comprises proprietary brain atlases (including The Rat Brain in Stereotaxic Coordinates, a high-resolution MRI atlas of the mouse brain, a 3D cross-modality atlas of the human brainstem, and a comprehensive in vivo MRI atlas of the human brain), the Sydney Brain Bank — Australia's only dedicated brain tissue repository for neurodegenerative disease research — the NeuRA Imaging facility (MRI), and the Transurban Road Safety Centre, Australia's first research-dedicated crash test lab. Adjacent translational assets include the PainWaive EEG neurofeedback system and digital tools such as Fallscreen, QuickScreen and the StandingTall balance app.
NeuRA's revenue model is diversified across NHMRC and ARC government research grants (subscription/recurring), individual donations, regular giving, gifts in wills and corporate engagement (donations), pharmaceutical-sponsored clinical trials and industry partnerships including licensing of atlas IP and co-development with biotech (licensing/royalties and professional services). The institute operates a hybrid go-to-market combining community-led participant recruitment, donor engagement and fundraising with sales-led industry partnerships and clinical trial contracting. The CEO is Professor Matthew Kiernan, and the institute's most prominent scientist is Professor George Paxinos AO, whose brain atlases are the most cited publication in neuroscience.
Neuroscience Research Australia firmographics
Firmographics- Name
- Neuroscience Research Australia
- Legal name
- Neuroscience Research Australia
- Website
- https://neura.edu.au
- Company type
- Private
- Founded year
- 1992
- Operating status
- Operating
- Headcount range
- 251–500 employees
- Short description
- Neuroscience Research Australia (NeuRA) is an independent, not-for-profit medical research institute in Randwick, NSW, conducting neuroscience research on dementia, Parkinson's, schizophrenia, chronic pain and falls for patients, clinicians, pharma partners and academic collaborators.
- Ownership category
- akta.pro rank
Neuroscience Research Australia industry classification
Industry- Product category
- Medical Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Medical Laboratories (621511)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- General Neurology (HLAKAIAA)
- akta.pro secondary industries
- Cognitive & Behavioral Neurology (Dementia/Memory Disorders) (HLAKAIAH), Movement Disorders (Parkinson’s, Tremor, Dystonia) (HLAKAIAC), Neuromuscular Medicine (ALS, Myasthenia, Neuropathy) (HLAKAIAD), Neurodiagnostic Centers (EEG/EMG/NCS) (HLAFAKAK)
Keywords
Where Neuroscience Research Australia is headquartered
LocationHeadquarters
- HQ city
- Randwick
- HQ country
- Australia
- HQ region
- Oceania
Offices1 record
Markets served
Neuroscience Research Australia business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- Government Research Grants: Funding from National Health and Medical Research Council (NHMRC), Australian Research Council (ARC), and other government bodies to support scientific research programs.
- Donations and Fundraising: Individual donations, regular giving programs, gifts in wills, and corporate engagement to support research activities.
- Clinical Trial Revenue: Partnerships with pharmaceutical and biotech companies conducting clinical trials at NeuRA facilities.
- Industry Partnerships and Collaborations: Strategic partnerships with pharmaceutical companies, healthcare organizations, and research institutions for co-development and research collaboration.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Other | Research publications and resources are freely available |
Go-to-market motion2 records
Distribution channels5 records
Marketing channels8 records
Neuroscience Research Australia product offering
Product offeringCore offering
Neuroscience Research Australia conducts independent medical research into brain and nervous system disorders including dementia, Parkinson's disease, motor neurone disease, schizophrenia, chronic pain, and falls prevention. The institute produces proprietary brain atlases, operates the Sydney Brain Bank tissue repository, runs clinical trials via Neuroscience Trials Australia, and translates research into clinical practice through partnerships with UNSW and South Eastern Sydney Local Health District.
Product overview
Neuroscience Research Australia (NeuRA) is an independent, not-for-profit medical research institute that conducts neuroscience research rather than selling commercial products. Its primary offerings are research publications, scientific atlases of brain anatomy, and the Sydney Brain Bank facility. Key products include various MRI/DTI brain atlases (mouse brain, human brainstem, in-vivo human brain) developed by Professor George Paxinos and collaborators, research publications on neurodegenerative diseases, dementia, and psychiatric conditions, and the Sydney Brain Bank which collects and stores brain tissue for research.
Differentiator
Problem solved
Functional benefit
Products and services
- High Resolution MRI Atlas of the Mouse Brain
- 3D Cross-Modality Atlas of the Human Brainstem
- Caress the Detail: Comprehensive MRI Atlas of the In Vivo Human Brain A comprehensive in-vivo MRI atlas defining approximately 800 brain structures, intended as a gold standard for science and clinical practice, available as both a tablet application and web service.
- Sydney Brain Bank A wholly-owned facility of NeuRA that collects, characterises and stores brain tissue for research into neurodegenerative disease including dementia, Parkinson's disease, motor neurone disease, and other neurological conditions.
- Neuroscience Trials Australia A clinical trial unit supporting patient identification and enrollment activities for pharmaceutical-sponsored clinical trials in Australia, including Phase 1b registrational trials for Parkinson's disease therapies.
- NeuRA Health Apps (Fallscreen, QuickScreen, ASRB, Falls Health Literacy Scale) A suite of digital tools and apps for assessing falls risk, balance, and health literacy, made available to clinicians, researchers, and the general public.
Quantifiable outcome
- Vision tests can predict dementia risk up to 12 years before diagnosis
- +3 more outcomes
Companies that use Neuroscience Research Australia
Customer profileNamed customers4 records
Segments5 records
Ideal customer profiles5 records
Neuroscience Research Australia technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
Neuroscience Research Australia partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered core and major.
- University of New South Wales (UNSW Sydney)coreNeuRA is an affiliated medical research institute of UNSW, located on the UNSW campus. The partnership includes joint research projects, shared facilities, academic appointments, and collaboration on the 10-year strategy 'Progress for All'. UNSW Chancellor David Gonski AC has expressed pride in NeuRA's calibre and contributions to the university.
- South Eastern Sydney Local Health District (SESLHD)coreFoundation partner of NeuRA, bringing clinical and research expertise in neurodegeneration, dementia and mental health. Joint vision to lead the Randwick Health & Innovation Precinct response to dementia and implement new models of care for Alzheimer's disease, neurodegeneration, and mental health.
- Parkinson's AustraliamajorPartnership established to support patient identification and enrollment in Serina Therapeutics' Parkinson's disease clinical trial in Australia.
- Neuroscience Trials AustraliamajorEstablished to support patient identification and enrollment activities for clinical trials conducted in Australia, including Serina Therapeutics' Phase 1b registrational trial for SER-252.
- UNSW Centre for Healthy Brain Ageing (CHeBA)coreCollaboration on brain health and dementia research, including the investigation of the brain microbiome and its influence on healthy brain ageing. Led by Dr Karen Mather at CHeBA working with Dr Claire Shepherd at NeuRA.
- Microbiome Research Centre at UNSWmajorCollaboration with Dr Fatima El-Assaad to investigate the existence of the brain microbiome using cutting-edge techniques to examine brains from healthy and neurodegenerative disease cases.
- Duke University (Al Johnson)majorCollaboration with Professor Al Johnson (Professor of Radiology, Physics, and Biomedical Engineering) for construction of electronic brain atlases combining MRI, magnetic resonance microscopy, and histological images.
- University of QueenslandmajorCollaboration through the Centre for Advanced Imaging for MRI atlas development, including Professor Markus Barth and collaboration on population-based atlases and high-resolution imaging.
- University of Wollongong (Associate Professor Mark Schira)majorCollaboration on 3D Cross-Modality Atlas of the Human Brainstem and ARC-funded child brain atlas project (AU$670,000 grant) for MRI atlas development.
- University of SydneymajorCollaboration on research including mixed neurodegenerative pathologies case series, dementia research, and cancer-related cognitive impairment studies with Professor Janette Vardy.
- Autism CRC Australian Autism BiobankmajorCollaboration providing samples from over 580 autistic children for hair cortisol and autism research, supported by Early Life Determinants of Health (ELDoH) Clinical Theme.
- Alfred HealthmajorCollaboration on case series examining neurodegenerative pathologies in former elite-level Australian rugby players, published in Journal of Neuropathology and Applied Neurobiology.
- Harvard Medical SchoolmajorCollaboration on research examining CTE and neurodegenerative pathologies in former athletes.
- Flinders UniversitymajorCollaboration with Professor Raymond Chan on cancer-related cognitive impairment research, including studies on candesartan for prevention.
- Queensland Alliance for Environmental Health Sciences (QAEHS) at University of QueenslandmajorCollaboration on PFAS chemicals research in human brains, analyzing brain-to-serum concentration ratios of PFAS substances.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
Neuroscience Research Australia competitors and assessment
Company assessmentDirect peers
- The Florey Institute of Neuroscience and Mental Health: Australia's largest independent medical research institute focused on neuroscience and mental health, headquartered in Melbourne. Operates the same not-for-profit, UNSW-equivalent model (university-affiliated), runs clinical trials and brain research across overlapping disease areas including dementia and Parkinson's.
- Queensland Brain Institute (QBI): University of Queensland-based neuroscience research institute working on dementia, motor neurone disease, mental health and brain imaging. Directly comparable as another Australian, university-affiliated neuroscience-focused institute delivering basic-to-translational research.
- Garvan Institute of Medical Research: Sydney-based, UNSW-affiliated independent medical research institute with overlapping focuses on genomics, immunology and neurodegeneration. Closest geographic and structural peer inside the same Australian medical research ecosystem.
- Montreal Neurological Institute-Hôpital (The Neuro): McGill-affiliated brain research institute combining basic neuroscience with clinical care across Parkinson's, Alzheimer's, epilepsy and rare neurological disease. Highly comparable translational neuroscience model with brain imaging and biobanking capability.
- UK Dementia Research Institute (UK DRI): National UK research consortium funded by the MRC, Alzheimer's Society and Alzheimer's Research UK, focused on discovery science and translational dementia research. Direct peer on dementia and neurodegeneration focus and non-profit multi-centre research model.
Broad incumbents
- Allen Institute for Brain Science: Large, well-funded US brain research organisation producing large-scale atlases and open neuroscience resources (including the Allen Brain Atlas). Adjacent technology and atlas-publishing overlap with NeuRA's Paxinos-led brain mapping franchise, and a broader scientific scope with much larger resources.
- Max Planck Institute for Brain Research: European basic-research neuroscience institute focused on neural circuits, development and disease. Comparable not-for-profit, government-funded basic neuroscience model at a broader international scale than NeuRA.
- Salk Institute for Biological Studies: Independent not-for-profit US biomedical research institute with significant neuroscience and neurodegeneration groups. Comparable operating model (independent research institute, grant-funded) though with a broader biological sciences mandate.
Others
- Howard Hughes Medical Institute (Janelia Research Campus): Large US biomedical research organisation funding and operating labs including Janelia's brain research and imaging programs. Comparable as a deep-pocketed funder of academic neuroscience infrastructure and atlas-style outputs, though not a direct translational research peer.
Regional players
- Centre for Brain Research at the University of Auckland: University-hosted neuroscience research centre in New Zealand covering neurodegeneration, stroke, brain imaging and dementia. Comparable as a regional Asia-Pacific neuroscience research peer, though NeuRA and this centre typically do not directly compete for the same sponsor trial patients.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights6 records
Customer concentration
Neuroscience Research Australia social profiles
Digital presenceNeuroscience Research Australia financial estimates
Financial estimateRevenue estimate
Valuation estimate
Neuroscience Research Australia leadership team
Management profileNumber of profiles
Profiles6 records
Neuroscience Research Australia subsidiaries and ownership
Company hierarchySubsidiaries1 record
Neuroscience Research Australia funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Neuroscience Research Australia M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Neuroscience Research Australia
What does Neuroscience Research Australia do?
Neuroscience Research Australia conducts independent medical research into brain and nervous system disorders including dementia, Parkinson's disease, motor neurone disease, schizophrenia, chronic pain, and falls prevention. The institute produces proprietary brain atlases, operates the Sydney Brain Bank tissue repository, runs clinical trials via Neuroscience Trials Australia, and translates research into clinical practice through partnerships with UNSW and South Eastern Sydney Local Health District.
Is Neuroscience Research Australia a public or private company?
Neuroscience Research Australia is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Neuroscience Research Australia founded?
Neuroscience Research Australia was founded in 1992. It employs 251 to 500 people.
Where is Neuroscience Research Australia based?
Neuroscience Research Australia is headquartered in Randwick, Australia, in the Oceania region.
How does Neuroscience Research Australia make money?
Four revenue lines are on record. Government Research Grants are the primary driver. The others are donations and Fundraising, clinical Trial Revenue and industry Partnerships and Collaborations.
Who are Neuroscience Research Australia's main competitors?
Direct peers on record are The Florey Institute of Neuroscience and Mental Health, Queensland Brain Institute (QBI), Garvan Institute of Medical Research, Montreal Neurological Institute-Hôpital (The Neuro) and UK Dementia Research Institute (UK DRI). Broad incumbents are Allen Institute for Brain Science, Max Planck Institute for Brain Research and Salk Institute for Biological Studies. Howard Hughes Medical Institute (Janelia Research Campus) is listed as an others. Centre for Brain Research at the University of Auckland is listed as a regional player.
Does Neuroscience Research Australia have an API?
No public API is recorded for Neuroscience Research Australia.
What industry is Neuroscience Research Australia in?
Neuroscience Research Australia's product category is Medical Research Services. Its primary akta.pro industry code is HLAKAIAA, General Neurology, with a secondary code of HLAKAIAH, Cognitive & Behavioral Neurology (Dementia/Memory Disorders). Its NAICS code is 541714 and its SIC code is 8731.